A detailed history of Acadian Asset Management LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,798 shares of BIO stock, worth $595,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,798
Previous 2,920 38.42%
Holding current value
$595,839
Previous $796,000 24.5%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$263.97 - $344.64 $296,174 - $386,686
-1,122 Reduced 38.42%
1,798 $601,000
Q2 2024

Aug 06, 2024

SELL
$268.26 - $339.48 $4.33 Million - $5.48 Million
-16,144 Reduced 84.68%
2,920 $796,000
Q1 2024

May 10, 2024

SELL
$304.11 - $351.99 $2.32 Million - $2.68 Million
-7,616 Reduced 28.55%
19,064 $6.59 Million
Q4 2023

Feb 13, 2024

SELL
$269.37 - $365.04 $2.36 Million - $3.19 Million
-8,745 Reduced 24.69%
26,680 $8.61 Million
Q3 2023

Nov 13, 2023

SELL
$350.25 - $422.63 $30.7 Million - $37 Million
-87,533 Reduced 71.19%
35,425 $12.7 Million
Q2 2023

Aug 07, 2023

SELL
$359.49 - $486.4 $45.1 Million - $61.1 Million
-125,578 Reduced 50.53%
122,958 $46.6 Million
Q1 2023

May 11, 2023

SELL
$418.69 - $503.0 $35.5 Million - $42.6 Million
-84,728 Reduced 25.42%
248,536 $119 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $20.9 Million - $27.1 Million
-59,438 Reduced 15.14%
333,264 $140 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $4.25 Million - $5.8 Million
-10,304 Reduced 2.56%
392,702 $164 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $4.25 Million - $5.8 Million
-10,304 Reduced 2.56%
392,702 $164 Million
Q2 2022

Aug 09, 2022

SELL
$463.67 - $597.16 $5.81 Million - $7.48 Million
-12,528 Reduced 3.01%
403,006 $199 Million
Q1 2022

May 12, 2022

BUY
$524.57 - $735.42 $2.12 Million - $2.98 Million
4,048 Added 0.98%
415,534 $234 Million
Q4 2021

Feb 10, 2022

SELL
$708.84 - $794.68 $8.07 Million - $9.05 Million
-11,389 Reduced 2.69%
411,486 $311 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $23.8 Million - $29.8 Million
36,122 Added 9.34%
422,875 $315 Million
Q2 2021

Aug 11, 2021

BUY
$576.64 - $649.04 $56.4 Million - $63.4 Million
97,754 Added 33.83%
386,753 $249 Million
Q1 2021

May 11, 2021

BUY
$547.01 - $662.35 $25 Million - $30.3 Million
45,687 Added 18.78%
288,999 $165 Million
Q4 2020

Feb 11, 2021

BUY
$510.68 - $643.45 $153,204 - $193,035
300 Added 0.12%
243,312 $142 Million
Q3 2020

Nov 09, 2020

SELL
$454.43 - $535.6 $10.2 Million - $12 Million
-22,355 Reduced 8.42%
243,012 $125 Million
Q2 2020

Aug 12, 2020

BUY
$334.87 - $493.06 $88.9 Million - $131 Million
265,367 New
265,367 $120 Million
Q4 2019

Feb 06, 2020

SELL
$319.73 - $374.2 $118 Million - $139 Million
-370,554 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$304.55 - $345.24 $113 Million - $128 Million
370,554 New
370,554 $123 Million
Q2 2019

Aug 08, 2019

SELL
$286.93 - $312.59 $147 Million - $160 Million
-513,409 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$224.3 - $317.41 $23.7 Million - $33.5 Million
-105,613 Reduced 17.06%
513,409 $157 Million
Q4 2018

Feb 07, 2019

SELL
$220.1 - $309.0 $18.6 Million - $26.2 Million
-84,725 Reduced 12.04%
619,022 $144 Million
Q3 2018

Oct 30, 2018

SELL
$289.28 - $326.15 $12.8 Million - $14.4 Million
-44,269 Reduced 5.92%
703,747 $220 Million
Q2 2018

Jul 24, 2018

SELL
$244.1 - $303.88 $13.9 Million - $17.3 Million
-56,935 Reduced 7.07%
748,016 $216 Million
Q1 2018

Apr 12, 2018

SELL
$233.97 - $274.11 $6.46 Million - $7.56 Million
-27,595 Reduced 3.31%
804,951 $201 Million
Q4 2017

Jan 18, 2018

SELL
$216.94 - $271.3 $12.5 Million - $15.6 Million
-57,531 Reduced 6.46%
832,546 $199 Million
Q3 2017

Oct 13, 2017

BUY
$212.27 - $242.28 $189 Million - $216 Million
890,077
890,077 $198 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.16B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.